A previous study by Wang et al. characterized tumor-specific CD4+ T cells derived from a melanoma patient and were the first to isolate antigen-specific Tregs, and further showed that cell-cell contact was required for T cell-mediated immune suppression in agreement with previous studies (135). This evidence concerns the gene CD4 and neoplasm.